
Mary M. Lyons
Examiner (ID: 4587, Phone: (571)272-2966 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1653 |
| Total Applications | 674 |
| Issued Applications | 377 |
| Pending Applications | 90 |
| Abandoned Applications | 228 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16557184
[patent_doc_number] => 20210002332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => SYSTEMS AND METHODS FOR FORMING BIOLOGICAL NANOWIRES AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/976971
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16976971
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/976971 | SYSTEMS AND METHODS FOR FORMING BIOLOGICAL NANOWIRES AND APPLICATIONS THEREOF | Feb 28, 2019 | Issued |
Array
(
[id] => 14435693
[patent_doc_number] => 20190175718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => NEISSERIA MENINGITIDIS VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/282080
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -98
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282080 | None | Feb 20, 2019 | Issued |
Array
(
[id] => 15055363
[patent_doc_number] => 10457973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Method for rapidly determining effective sterilization, deimmunization, and/or disinfection
[patent_app_type] => utility
[patent_app_number] => 16/275721
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 22
[patent_no_of_words] => 19878
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275721 | Method for rapidly determining effective sterilization, deimmunization, and/or disinfection | Feb 13, 2019 | Issued |
Array
(
[id] => 16629021
[patent_doc_number] => 20210047674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => SAMPLING OF MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 16/967876
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967876 | Sampling of microorganisms | Feb 7, 2019 | Issued |
Array
(
[id] => 18619311
[patent_doc_number] => 11752335
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-12
[patent_title] => Method for determining facial muscle responses
[patent_app_type] => utility
[patent_app_number] => 16/270211
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10022
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270211 | Method for determining facial muscle responses | Feb 6, 2019 | Issued |
Array
(
[id] => 15978507
[patent_doc_number] => 10669563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Method for the production of protein complexes and vaccine compositions comprising the same
[patent_app_type] => utility
[patent_app_number] => 16/270406
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11119
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270406 | Method for the production of protein complexes and vaccine compositions comprising the same | Feb 6, 2019 | Issued |
Array
(
[id] => 14655609
[patent_doc_number] => 20190234933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => COMPOSITIONS AND ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/265705
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265705 | COMPOSITIONS AND ASSAYS | Jan 31, 2019 | Abandoned |
Array
(
[id] => 18314152
[patent_doc_number] => 11628213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Ichthyophthirius multifiliis vaccine system
[patent_app_type] => utility
[patent_app_number] => 16/963761
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 33
[patent_no_of_words] => 17439
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963761 | Ichthyophthirius multifiliis vaccine system | Jan 22, 2019 | Issued |
Array
(
[id] => 16680737
[patent_doc_number] => 10940193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Controlled release vaccines and methods for treating
[patent_app_type] => utility
[patent_app_number] => 16/251757
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 30
[patent_no_of_words] => 19058
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16251757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/251757 | Controlled release vaccines and methods for treating | Jan 17, 2019 | Issued |
Array
(
[id] => 14838891
[patent_doc_number] => 20190277846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => BIOMARKERS OF LATENT TUBERCULOSIS INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/246592
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246592 | Biomarkers of latent tuberculosis infection | Jan 13, 2019 | Issued |
Array
(
[id] => 14231275
[patent_doc_number] => 20190127810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SEQUENCE-SPECIFIC DETECTION AND PHENOTYPE DETERMINATION
[patent_app_type] => utility
[patent_app_number] => 16/245093
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245093 | Sequence-specific detection and phenotype determination | Jan 9, 2019 | Issued |
Array
(
[id] => 16290097
[patent_doc_number] => 10766933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Mutated immunoglobulin-binding protein having increased alkaline tolerance
[patent_app_type] => utility
[patent_app_number] => 16/240074
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9924
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240074 | Mutated immunoglobulin-binding protein having increased alkaline tolerance | Jan 3, 2019 | Issued |
Array
(
[id] => 15813799
[patent_doc_number] => 10632056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Supplement to support healthy hair, skin, and nails
[patent_app_type] => utility
[patent_app_number] => 16/238592
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6866
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16238592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/238592 | Supplement to support healthy hair, skin, and nails | Jan 2, 2019 | Issued |
Array
(
[id] => 16961426
[patent_doc_number] => 20210212925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => MAKE-UP COMPOSITION COMPRISING A HYDROLYSATE OF THEOBROMA CACAO L BEANS AND AT LEAST ONE PREBIOTIC AND A PROBIOTIC
[patent_app_type] => utility
[patent_app_number] => 16/956071
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956071 | MAKE-UP COMPOSITION COMPRISING A HYDROLYSATE OF THEOBROMA CACAO L BEANS AND AT LEAST ONE PREBIOTIC AND A PROBIOTIC | Dec 20, 2018 | Pending |
Array
(
[id] => 16512813
[patent_doc_number] => 20200392071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host
[patent_app_type] => utility
[patent_app_number] => 16/954461
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 940
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954461 | Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host | Dec 20, 2018 | Abandoned |
Array
(
[id] => 16443671
[patent_doc_number] => 10835575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Compositions and methods for treating disease using
[patent_app_type] => utility
[patent_app_number] => 16/227802
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 17594
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227802 | Compositions and methods for treating disease using | Dec 19, 2018 | Issued |
Array
(
[id] => 14468389
[patent_doc_number] => 20190185837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/228285
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228285 | BOTULINUM TOXIN CELL BINDING DOMAIN POLYPEPTIDES AND METHODS OF USE FOR TREATMENTS OF FIBROSIS ASSOCIATED DISORDERS | Dec 19, 2018 | Abandoned |
Array
(
[id] => 14464695
[patent_doc_number] => 20190183987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => NEUROTOXINS FOR USE IN MINIMIZING SCARRING
[patent_app_type] => utility
[patent_app_number] => 16/224192
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224192 | NEUROTOXINS FOR USE IN MINIMIZING SCARRING | Dec 17, 2018 | Abandoned |
Array
(
[id] => 17421267
[patent_doc_number] => 11254709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Method for promoting
[patent_app_type] => utility
[patent_app_number] => 16/220019
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4230
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220019 | Method for promoting | Dec 13, 2018 | Issued |
Array
(
[id] => 16468550
[patent_doc_number] => 20200370087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => METHOD FOR DETERMINING MICROBIAL SUSCEPTIBILITY TO ANTIBIOTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/767722
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767722 | METHOD FOR DETERMINING MICROBIAL SUSCEPTIBILITY TO ANTIBIOTIC AGENTS | Nov 29, 2018 | Abandoned |